Project Grant K23AR084603
Award Date
7/1/24
Completion Date
6/30/29
Dollars Obligated
$175K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $348,680 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Arizona to develop computational tools for predicting and understanding different spatial patterns of knee pain in osteoarthritis patients. The key products and services to be delivered under this 2-year award include: Adapting a transformer-based deep learning approach to accurately predict...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $1,205,522 to the University of Chicago to conduct a pilot study on the use of Genicular Artery Embolization (GAE) to reduce pain in patients with medically refractory mild to moderate knee osteoarthritis. The key objectives are to establish the feasibility of enrollment and quantify the...
This federal Project Grant award, valued at $347,056, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support research to evaluate the role of vitamin K levels and the vitamin K-dependent matrix GLA protein (MGP) in structural and symptomatic outcomes of knee osteoarthritis. Key objectives include assessing blood thresholds of vitamin K...
This Project Grant award of $142,000.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the mechanisms underlying sex differences in the emergence of advanced osteoarthritis (OA) pain. The key objectives are to: Determine pathological sprouting of sensory nerves in the knee joint and surrounding muscle of male and female mice with mid-stage and advanced OA pain. This will...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $711,161 to Northwestern University to conduct research on defining and validating guidelines for interpreting commonly used patient-reported outcome measures (PROMs) in the care of patients with advanced knee osteoarthritis. The research aims to generate guidelines tailored to...
This $123,040 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the therapeutic potential of the NFAT1 transcription factor in treating osteoarthritis (OA). The research will be conducted by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) over a 5-year project period from August 1, 2024 to July 31, 2029. The...
This federal Project Grant award of $1,288,152.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award, which commenced on September 20, 2024 and is scheduled for completion by August 31, 2026, is supporting research by Tufts University School of Medicine to develop a high-throughput screening approach called "JointSeq" to identify...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1,066,302 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Massachusetts Medical School (UMass Medical) to create a centralized knowledgebase for the Osteoarthritis Initiative (OAI), a large-scale observational study. The knowledgebase will extract, accumulate, organize, annotate, and link data from the OAI, including clinical information, medical...
This federal Project Grant award, valued at $409,612.00 and awarded on September 24, 2024, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The primary awardee, The Spaulding Rehabilitation Hospital Corporation, will conduct research to investigate the neural correlates of self-regulation and its association with pain catastrophizing in patients with chronic...
This federal Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to investigate the synergistic effects of mechanical and hormonal signals on increasing bone mass. The 5-year, $175,948 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to elucidate the molecular mechanisms by which...